Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


31.10.2022

2 AJR Am J Roentgenol
9 Anticancer Res
2 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Surg
1 Dig Dis
4 Dig Dis Sci
1 Endoscopy
3 Gastroenterology
1 Gut
1 Hepatology
1 J Gastroenterol
1 J Gastroenterol Hepatol
1 J Hepatol
1 Nat Rev Cancer
1 Oncogene
1 Proc Natl Acad Sci U S A
2 Radiology
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. BARR RG
    Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic.
    AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.28113.
    PubMed        

  2. TSE JR, Shen L, Bird KN, Yoon L, et al
    Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.27812.
    PubMed         Abstract available


    Anticancer Res

  3. TAKEDA S, Namisaki T, Tsuji Y, Fujimoto Y, et al
    Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study.
    Anticancer Res. 2022;42:5465-5473.
    PubMed         Abstract available

  4. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
    Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2022;42:5497-5505.
    PubMed         Abstract available

  5. YUEH TC, Tsao HY, Chien WC, Tsai CW, et al
    The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility.
    Anticancer Res. 2022;42:5275-5282.
    PubMed         Abstract available

  6. HUANG G, Howard LN, Alonsozana E, Sill D, et al
    Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient.
    Anticancer Res. 2022;42:5475-5478.
    PubMed         Abstract available

  7. SASAKI T, Shigeta K, Kitahara S, Suzuki Y, et al
    Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment.
    Anticancer Res. 2022;42:5205-5215.
    PubMed         Abstract available

  8. SCHMITZ V, Bauerschmitz G, Gallwas J, Grundker C, et al
    Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERbeta Agonists.
    Anticancer Res. 2022;42:5187-5194.
    PubMed         Abstract available

  9. KIM SH, Song SE, Baik H, Hur DY, et al
    15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by Up-regulation of Epithelial-to-Mesenchymal Transition Genes.
    Anticancer Res. 2022;42:5385-5396.
    PubMed         Abstract available

  10. KOMATSU S, Yano Y, Kido M, Kuramitsu K, et al
    Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:5479-5486.
    PubMed         Abstract available

  11. YAMAMURA K, Beppu T, Inoue K, Matsumura K, et al
    Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus.
    Anticancer Res. 2022;42:5663-5670.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  12. SAMERI MJ, Savari F, Hoseinynejad K, Danyaei A, et al
    The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
    Biochem Biophys Res Commun. 2022;635:194-202.
    PubMed         Abstract available

  13. ZHANG F, Wu J, Ruan H, Xia J, et al
    ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Biochem Biophys Res Commun. 2022;632:129-138.
    PubMed         Abstract available


    BMC Cancer

  14. MO M, Ma X, Luo Y, Tan C, et al
    Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
    BMC Cancer. 2022;22:1098.
    PubMed         Abstract available


    Br J Surg

  15. LOPEZ-LOPEZ V, Sanchez-Esquer I, Crespo MJ, Navarro MA, et al
    Development and validation of advanced three-dimensional navigation device integrated in da Vinci Xi(R) surgical robot for hepatobiliary surgery: pilot study.
    Br J Surg. 2022 Oct 26. pii: 6775136. doi: 10.1093.
    PubMed        


    Dig Dis

  16. WANG X, Zhang J, Luo F, Shen Y, et al
    Application of CircRNA Circ_0071662 in the diagnosis and prognosis of hepatocellular carcinoma and its response to radiotherapy.
    Dig Dis. 2022 Oct 24. pii: 000527696. doi: 10.1159/000527696.
    PubMed         Abstract available


    Dig Dis Sci

  17. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
    Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:5272-5279.
    PubMed         Abstract available

  18. YEBOAH-KORANG A, Memon A, Patel N, Portocarrero-Castillo A, et al
    Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Dig Dis Sci. 2022;67:5262-5271.
    PubMed         Abstract available

  19. SARAIREH H, Abdelfattah T, Hassouneh R, Lippman R, et al
    "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease.
    Dig Dis Sci. 2022;67:5256-5261.
    PubMed         Abstract available

  20. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
    Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Dig Dis Sci. 2022;67:5327-5335.
    PubMed         Abstract available


    Endoscopy

  21. OGURA T, Uba Y, Yamamura M, Kawai J, et al
    Successful endoscopic ultrasound-guided hepaticogastrostomy with use of a novel drill dilator for challenging tract dilation.
    Endoscopy. 2022 Oct 28. doi: 10.1055/a-1956-0763.
    PubMed        


    Gastroenterology

  22. BLAIR AB, Wang J, Davelaar J, Baker A, et al
    Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
    Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
    PubMed         Abstract available

  23. PRASOPPOKAKORN T, Rerknimitr R
    An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
    Gastroenterology. 2022;163:1186-1187.
    PubMed        

  24. MAGAHIS P, Rosenblatt R, Mahadev S
    An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
    Gastroenterology. 2022;163:e3-e5.
    PubMed        


    Gut

  25. ZHAO Y, Yeo YH, Samaan J, Lv F, et al
    Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19.
    Gut. 2022 Sep 5. pii: gutjnl-2022-328188. doi: 10.1136/gutjnl-2022-328188.
    PubMed        


    Hepatology


  26. Erratum for Jiang L, et al. calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway.
    Hepatology. 2022 Oct 26. doi: 10.1002/hep.32796.
    PubMed        


    J Gastroenterol

  27. LIN YC, Lin HF, Wu CC, Chen CL, et al
    Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
    J Gastroenterol. 2022;57:913-925.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  28. GORGANI F, Esfahani Z, Ghamari SH, Ghasemi E, et al
    Global, Regional, and National Burden and Quality of Care Index of Liver Cirrhosis by Cause from Global Burden of Disease 1990-2019.
    J Gastroenterol Hepatol. 2022 Oct 26. doi: 10.1111/jgh.16041.
    PubMed         Abstract available


    J Hepatol

  29. PRYKE R, Guha IN
    Time to focus chronic liver diseases back into the community: A review of primary care hepatology tools, pathways of care and reimbursement mechanisms.
    J Hepatol. 2022 Oct 22. pii: S0168-8278(22)03146.
    PubMed         Abstract available


    Nat Rev Cancer

  30. SENFT D
    Platelets limit liver tumours.
    Nat Rev Cancer. 2022;22:608.
    PubMed        


    Oncogene

  31. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021;40:2581-2595.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  32. ZHOU Q, Kang G, Jiang P, Qiao R, et al
    Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Proc Natl Acad Sci U S A. 2022;119:e2209852119.
    PubMed         Abstract available


    Radiology

  33. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    PubMed         Abstract available

  34. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
    Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
    PubMed         Abstract available


    Transplantation

  35. TEJEDOR M, Selzner N, Berenguer M
    Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
    Transplantation. 2022 May 16. pii: 00007890-990000000-00049.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: